Literature DB >> 28806800

Review: Osteoporosis drugs may improve BMD and reduce fractures in some patients with CKD.

Susan M Ott.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28806800     DOI： 10.7326/ACPJC-2017-167-4-019

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.

Authors:  Rachel M Holden; Reem A Mustafa; R Todd Alexander; Marisa Battistella; Micheli U Bevilacqua; Greg Knoll; Fabrice Mac-Way; Martina Reslerova; Ron Wald; Philip D Acott; Patrick Feltmate; Allan Grill; Kailash K Jindal; Meena Karsanji; Bryce A Kiberd; Sara Mahdavi; Kailee McCarron; Amber O Molnar; Maury Pinsk; Celia Rodd; Steven D Soroka; Amanda J Vinson; Deborah Zimmerman; Catherine M Clase
Journal:  Can J Kidney Health Dis       Date:  2020-08-04

2.  Bone Turnover Status: Classification Model and Clinical Implications.

Authors:  Alexander Fisher; Leon Fisher; Wichat Srikusalanukul; Paul N Smith
Journal:  Int J Med Sci       Date:  2018-02-01       Impact factor: 3.738

3.  MicroRNA-197-3p Inhibits the Osteogenic Differentiation in Osteoporosis by Down-Regulating KLF 10.

Authors:  Murong You; Liang Zhang; Xiaoxiang Zhang; Yang Fu; Xieping Dong
Journal:  Clin Interv Aging       Date:  2021-01-11       Impact factor: 4.458

4.  Bisphosphonates and bone mineral density in patients with end-stage kidney disease and renal transplants: A 15-year single-centre experience.

Authors:  Dominic Hauck; Liza Nery; Rachel O'Connell; Roderick Clifton-Bligh; Amanda Mather; Christian M Girgis
Journal:  Bone Rep       Date:  2022-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.